BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
IVDs on the rise
Radiopharmaceuticals
Science '22 in Review
Top Biopharma Trends of 2022
Top Med-tech Trends of 2022
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, October 1, 2023
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Absci and University of Oxford partner on discovery and development of therapies for immune-mediated diseases
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Gastrointestinal
Absci and University of Oxford partner on discovery and development of therapies for immune-mediated diseases
May 12, 2023
No Comments
Absci Corp. and the University of Oxford’s...
BioWorld Science
Drug design, drug delivery and technologies
Collaboration
Gastrointestinal
Immune
Inflammatory
